Jubereq 120 mg/1.7 ml, Injektionslösung

7680700940016 CH-70094 Injektionslösung

Associated product:

JUBEREQ 120 mg/1.7 ml sol inj 120 mg 1 pce

No image available

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
20/05/2026
Summary of Product Characteristics
Français
20/05/2026
Summary of Product Characteristics
Italien
20/05/2026

Detailed composition

Substance Quantity Type Category
denosumabum
120.0 MG Substance Wirkstoff (Principe actif)
polysorbatum 20
- Substance HNIDK
sorbitolum
78.2 MG Substance HBESI
acidum aceticum glaciale
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 210.45
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2026

Authorization holder

Accord Healthcare AG

4103 Bottmingen

Authorization information

Swissmedic authorization number
70094
Drug name
Jubereq, Injektionslösung
Galenic form
LSINJ
ATC Code
M05BX04
Authorization status
Z
Dispensing category
A
First authorization
29/04/2026
Authorization expiration date
28/04/2031
IT Number
07.16.1.
Domain
Human medicine
Field of application
Knochenmetastasen solider Tumoren; Riesenzelltumoren des Knochens

Package details

Description (FR)
JUBEREQ 120 mg/1.7 ml sol inj 120 mg 1 pce
Description (DE)
JUBEREQ 120 mg/1.7 ml Inj Lös 120 mg 1 Stk
Market launch
05/06/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data